Our mission is to reduce the global impact of infectious diseases through the development of affordable innovative products, with a special focus on those diseases affecting people in low- and middle income countries. Many infectious diseases don’t have a vaccine or a cure, and if they exist they are not widely available because of manufacturing, distribution or pricing issues. The doubtful commercial viability of these drugs makes them unattractive for most pharmaceutical companies.

We pursue a new business model in the pharmaceutical industry based on ensuring the widespread availability of our products.